Alzheimer’s Accountability and Investment Act

Alzheimer's Accountability and Investment Act

This bill requires the National Institutes of Health to annually submit, beginning in FY2024, an estimate of its budget and personnel needs for carrying out initiatives pursuant to the National Alzheimer's Project. This project supports coordination of federal planning, research, and other efforts to address Alzheimer's disease and related dementias.

The Alzheimer’s Accountability and Investment Act, also known as Bill 117 hr 7773, is a piece of legislation introduced in the US Congress aimed at addressing the growing issue of Alzheimer’s disease. The bill focuses on increasing funding for research, treatment, and support services for individuals and families affected by Alzheimer’s.

One of the key provisions of the bill is the establishment of a National Alzheimer’s Project Office within the Department of Health and Human Services. This office would be responsible for coordinating federal efforts related to Alzheimer’s research, treatment, and care. The bill also calls for the creation of a National Alzheimer’s Advisory Council, which would provide recommendations to the Secretary of Health and Human Services on how to best address the needs of individuals with Alzheimer’s.

In addition to these provisions, the bill also includes measures to increase funding for Alzheimer’s research and support services. This includes funding for research into the causes and potential treatments for Alzheimer’s, as well as funding for programs that provide support services for individuals and families affected by the disease. Overall, the Alzheimer’s Accountability and Investment Act aims to increase awareness of Alzheimer’s disease, improve access to care and support services, and ultimately find a cure for this devastating illness. By increasing funding and coordination at the federal level, the bill seeks to make a meaningful impact on the lives of those affected by Alzheimer’s.